3-Bromo-6-isopropylpyridazine

Catalog No.: 
ACTOPC134
CAS No.: 
1086383-70-1
Molecular Formula: 
C7H9BrN2
Molecular Weight: 
201.07
3-Bromo-6-isopropylpyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$102.00In stockInquiry
250mg98%$171.00In stockInquiry
1g98%$420.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-6-isopropylpyridazine
IUPAC Name3-bromo-6-isopropylpyridazine
MDL No.MFCD11223461
Molecular FormulaC7H9BrN2
Molecular Weight201.07
SMILESCC(C1=NN=C(Br)C=C1)C
InChI KeyJUILXVOYPCXJHW-UHFFFAOYSA-N
SynonymPyridazine, 3-broMo-6isopropyl;3-BroMo-6-isopropylpyridazine;3-bromo-6-propan-2-ylpyridazine;Pyridazine, 3-bromo-6-(1-methylethyl)-
CAS No.1086383-70-1
PubChem CID45787810

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTOPC134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNZKS540 route compound structure diagram
    ACNZKS540570416-36-3In Stock
  2. Then
  3. ACTOPC134 route product structure diagram
    ACTOPC1341086383-70-1In Stock
Inquiry

2. ACTOPC134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJGSQ357 route compound structure diagram
    ACJGSQ35717973-86-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTOPC134 route product structure diagram
    ACTOPC1341086383-70-1In Stock
Inquiry

3. ACTOPC134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOPC134 route product structure diagram
    ACTOPC1341086383-70-1In Stock
Inquiry

Comments (0)